相关实验视频
Updated: Jun 11, 2025

10:36
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
12.0K
在计算机和诊所中,罕见的癌症突变的中性演变
1Department of Oncology, Georgetown University Medical Center, Washington, DC, USA. eniac1915@gmail.com.
NPJ systems biology and applications
|October 2, 2024
概括
罕见癌症突变中性进化的新模型挑战了无限位点假设. 该模型预测了临床癌症的显著遗传多样性,这可能解释了治疗耐药性.
科学领域:
- 遗传学 是一个遗传学.
- 进化生物学 进化生物学
- 癌症研究 癌症研究
背景情况:
- 癌症进化通常是使用无限位点近似来建模的.
- 这种假设假定每个突变在任何给定的时间只在一个细胞中发生.
- 该模型对临床癌症的适用性仍在研究中.
研究的目的:
- 描述罕见癌症突变中性进化的独特模型.
- 为了将这个新模型与现有的模型进行对比,特别是无限位点近似.
- 探索这个模型对理解癌症进展和治疗阻抗性的影响.
主要方法:
- 开发一种用于癌症突变中性演变的新理论模型.
- 对新模型与无限位点近似进行比较分析.
- 对临床相关细胞数量的模型预测的探索.
主要成果:
- 为罕见的癌症突变建立了一个独特的中性进化模型.
- 新模型预测,在临床细胞数量下,遗传多样性将出现显著的"爆炸".
- 这种预测的多样性可能解释了治疗期间在癌症中观察到的渐进性折射性.
结论:
- 无限位点近似可能不适合对临床癌症进行建模.
- 拟议的模型为癌症进展中的基因多样性和治疗耐药性增加提供了潜在的解释.
- 需要进一步的研究来验证这些预测在临床环境中.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

